Evidence map›Paper›PMID 40352384›Full record

ArticleRSC advances2025

Preparation and characterization of HfOC/SiOC composite powders and fibermats

Arijit Roy, Paul Owiredu, Gurpreet Singh

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arijit RoyMechanical and Nuclear Engineering Department, Kansas State University Manhattan KS 66506 USA arijit@ksu.edu gurpreet@ksu.edu.ORCID https://orcid.org/0009-0004-8026-2330
Paul OwireduMechanical and Nuclear Engineering Department, Kansas State University Manhattan KS 66506 USA arijit@ksu.edu gurpreet@ksu.edu.ORCID https://orcid.org/0009-0004-6892-1348
Gurpreet SinghMechanical and Nuclear Engineering Department, Kansas State University Manhattan KS 66506 USA arijit@ksu.edu gurpreet@ksu.edu.ORCID https://orcid.org/0000-0003-2126-9204

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on the synthesis and characterization of HfOC/SiOC ceramic composite powders and electrospun fibermats, which integrate the high-temperature resilience of HfOC with the oxidation resistance of silicon oxycarbide (SiOC). The composites were fabricated through a polymer-pyrolysis route by integrating 1,3,5,7-tetramethyl, 1,3,5,7-tetravinyl cyclotetrasiloxane (4-TTCS), a precursor source for SiOC, and a commercial HfC precursor in a 1 : 1 ratio by mass. First, the HfC precursor was heated to 70 °C to drive off water molecules, followed by its blending with the liquid phase 4-TTCS and cross-linking at a moderate temperature (160-400 °C). This was followed by pyrolysis at three different temperatures - 800, 1000, and 1200 °C in an inert argon atmosphere. The composite ceramic was comprehensively characterized by the use of electron microscopy for particle and fiber morphology, X-ray diffraction for the evolution of various ceramic phases, and a range of spectroscopies to document the change in molecular vibrations or the evolution of the functional groups and molecular bonding in preceramic polymer during cross-linking and ceramization. The crosslinked polymer-to-ceramic yield for powder samples was observed to be as high as approximately 78 wt% when pyrolyzed at 800 °C, and 74 wt% when pyrolyzed at 1200 °C. The oxidation test performed at 800 °C in stagnant air for the fibermat pyrolyzed at 1000 °C indicated a linear shrinkage of 6% for the HfOC/SiOC composite. This represents an improvement over the carbon rich-SiOC fibermat which exhibited a mass loss of 71 wt% and a linear shrinkage of nearly 19%, while the neat carbon fibermat was completely burned off under similar conditions.

Identifiers

PMID40352384
PMCPMC12063723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.